INMUNOENSAYO PARA LA DETERMINACIÓN DE ANTICUERPOS RECEPTORES DE TIROTROPINA (TRAB)
Mexico·Clase I·III. Agentes de diagnóstico·INSUMOS PARA LA
SALUD, S.A. DE C.V.·Registered November 07, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- MAGLUMI® ANTICUERPOS RECEPTORES DE TIROTROPINA (CLIA)
- Trade Name (English)
- MAGLUMI® ANTICUERPOS RECEPTORES DE TIROTROPINA (CLIA)
- Analysis ID
- 1291R2022 SSA
- Registration Date
- November 07, 2022
- Name (Spanish)
- INSUMOS PARA LA SALUD, S.A. DE C.V.
- Name (English)
- INSUMOS PARA LA SALUD, S.A. DE C.V.
Access comprehensive regulatory information for INMUNOENSAYO PARA LA DETERMINACIÓN DE ANTICUERPOS RECEPTORES DE TIROTROPINA (TRAB) (INMUNOENSAYO PARA LA DETERMINACIÓN DE ANTICUERPOS RECEPTORES DE TIROTROPINA (TRAB)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1291R2022 SSA and manufactured by INSUMOS PARA LA SALUD, S.A. DE C.V.. The device was registered on November 07, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.